Analyst Research

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: S&P Capital IQ Factual Report
$150.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cubist Pharmaceuticals Inc issues voluntary nationwide recall of one lot of cubicin due to presence of particulate matter


Friday, 18 Apr 2014 11:59am EDT 

Cubist Pharmaceuticals Inc:Says it is voluntarily recalling one lot of CUBICIN (daptomycin for injection) to the user level due to the presence of particulate matter, reported via customer complaint and identified as glass particles, found in a single vial from this lot, produced by a contract manufacturer. 

Company Quote

62.58
-3.12 -4.75%
23 Jul 2014